The past, present and future of HIV-vaccine development: a critical view

被引:15
作者
Bojak, A [1 ]
Deml, L [1 ]
Wagner, R [1 ]
机构
[1] Inst Med Microbiol & Hyg, D-93053 Regensburg, Germany
关键词
D O I
10.1016/S1359-6446(01)02081-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Despite the extensive efforts that have been made to combat AIDS, the global number of HIV-1 infections is still increasing. There is major consent among scientists worldwide, that the development of successful HIV vaccine strategies requires a profound understanding of the epidemiological principles of a viral pandemic, as well as deep insights into the molecular and immunological mechanisms of HIV pathogenesis. This review provides an overview of past and present developments, as well as future aspects of HIV vaccines, and also provides a summary of current clinical trials in man.
引用
收藏
页码:36 / 46
页数:11
相关论文
共 84 条
[1]   THE IMMUNOLOGICAL PRINCIPLES OF VACCINATION [J].
ADA, GL .
LANCET, 1990, 335 (8688) :523-526
[2]   Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].
Amara, RR ;
Villinger, F ;
Altman, JD ;
Lydy, SL ;
O'Neil, SP ;
Staprans, SI ;
Montefiori, DC ;
Xu, Y ;
Herndon, JG ;
Wyatt, LS ;
Candido, MA ;
Kozyr, NL ;
Earl, PL ;
Smith, JM ;
Ma, HL ;
Grimm, BD ;
Hulsey, ML ;
Miller, J ;
McClure, HM ;
McNicholl, JM ;
Moss, B ;
Robinson, HL .
SCIENCE, 2001, 292 (5514) :69-74
[3]   Construction of attenuated HIV-1 accessory gene immunization cassettes [J].
Ayyavoo, V ;
Nagashunmugam, T ;
Phung, MT ;
Buckner, C ;
Kudckodkar, S ;
Le, P ;
Reddy, PJ ;
Santiago, L ;
Patel, M ;
Tea, L ;
Weiner, DB .
VACCINE, 1998, 16 (19) :1872-1879
[4]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[5]   NEUTRALIZING ANTIBODIES TO HIV-1 IN SERONEGATIVE VOLUNTEERS IMMUNIZED WITH RECOMBINANT GP120 FROM THE MN STRAIN OF HIV-1 [J].
BELSHE, RB ;
GRAHAM, BS ;
KEEFER, MC ;
GORSE, GJ ;
WRIGHT, P ;
DOLIN, R ;
MATTHEWS, T ;
WEINHOLD, K ;
BOLOGNESI, DP ;
SPOSTO, R ;
STABLEIN, DM ;
TWADDELL, T ;
BERMAN, PW ;
GREGORY, T ;
IZU, AE ;
WALKER, MC ;
FAST, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (06) :475-480
[6]   Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers [J].
Belshe, RB ;
Gorse, GJ ;
Mulligan, MJ ;
Evans, TG ;
Keefer, MC ;
Excler, JL ;
Duliege, AM ;
Tartaglia, J ;
Cox, WI ;
McNamara, J ;
Hwang, KL ;
Bradney, A ;
Montefiori, D ;
Weinhold, KJ .
AIDS, 1998, 12 (18) :2407-2415
[7]   Development of bivalent (B/E) vaccines able to neutralize CCR5-dependent viruses from the United States and Thailand [J].
Berman, PW ;
Huang, W ;
Riddle, L ;
Gray, AM ;
Wrin, T ;
Vennari, J ;
Johnson, A ;
Klaussen, M ;
Prashad, H ;
Köhne, C ;
DeWit, C ;
Gregory, TJ .
VIROLOGY, 1999, 265 (01) :1-9
[8]   Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene [J].
Berthet, FX ;
Lagranderie, M ;
Gounon, P ;
Laurent-Winter, C ;
Ensergueix, D ;
Chavarot, P ;
Thouron, F ;
Maranghi, E ;
Pelicic, V ;
Portnoï, D ;
Marchal, G ;
Gicquel, B .
SCIENCE, 1998, 282 (5389) :759-762
[9]   Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians [J].
Betts, MR ;
Krowka, J ;
Santamaria, C ;
Balsamo, K ;
Gao, F ;
Mulundu, G ;
Luo, CW ;
NGandu, N ;
Sheppard, H ;
Hahn, BH ;
Allen, S ;
Frelinger, JA .
JOURNAL OF VIROLOGY, 1997, 71 (11) :8908-8911
[10]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110